Format

Send to

Choose Destination
Vet Immunol Immunopathol. 2008 May 15;123(1-2):172-5. doi: 10.1016/j.vetimm.2008.01.026. Epub 2008 Jan 19.

Treatment of cats with feline infectious peritonitis.

Author information

1
Department of Small Animal Internal Medicine, LMU University of Munich, Veterinaerstrasse 13, 80539 Muenchen, Germany. Hartmann@uni-muenchen.de

Abstract

Feline infectious peritonitis (FIP) infection resulting in clinical signs is invariably fatal despite clinical intervention. As FIP is an immune-mediated disease, treatment is mainly aimed at controlling the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression but do not produce a cure. In nearly every published case report of attempted therapy for clinical FIP, glucocorticoids have been used; there are, however, no controlled studies that evaluate the effect of glucocorticoids as a therapy for FIP. Some veterinarians prescribe immune modulators to treat cats with FIP with no documented controlled evidence of efficacy. It has been suggested that these agents may benefit infected animals by restoring compromised immune function, thereby allowing the patient to control viral burden and recover from clinical signs. However, a non-specific stimulation of the immune system may be contraindicated as clinical signs develop and progress as a result of an immune-mediated response to the mutated FCoV.

PMID:
18395801
DOI:
10.1016/j.vetimm.2008.01.026
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center